Mirogabalin in Japanese Patients with Renal Impairment and Pain Associated with Diabetic Peripheral Neuropathy or Post-Herpetic Neuralgia: A Phase III, Open-Label, 14-Week Study

PURPOSE: Mirogabalin was recently approved in Japan for the treatment of peripheral neuropathic pain, based on data from clinical trials in diabetic peripheral neuropathic pain (DPNP) and post-herpetic neuralgia (PHN), common clinical conditions which cause intense distress for patients. We characte...

Descripción completa

Detalles Bibliográficos
Autores principales: Baba, Masayuki, Takatsuna, Hiroshi, Matsui, Norimitsu, Ohwada, Shoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381826/
https://www.ncbi.nlm.nih.gov/pubmed/32765056
http://dx.doi.org/10.2147/JPR.S255345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381826/
https://www.ncbi.nlm.nih.gov/pubmed/32765056
http://dx.doi.org/10.2147/JPR.S255345

Ejemplares similares